Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma

Clinical trial NCT07754682 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07754682
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chimeric Antigen Receptor T-cell Therapy B Cell Acute Lymphoblastic Leukemia (B-ALL)B Cell Lymphoma Antibiotic Prophylaxis Immunoglobulin Therapy

Start date: 2026-09-01
Primary completion: 2029-09-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.